tradingkey.logo
tradingkey.logo
Search

ASP Isotopes Inc

ASPI
Add to Watchlist
5.630USD
-0.540-8.75%
Close 07/02, 13:00ETQuotes delayed by 15 min
708.84MMarket Cap
LossP/E TTM

More Details of ASP Isotopes Inc Company

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

ASP Isotopes Inc Info

Ticker SymbolASPI
Company nameASP Isotopes Inc
IPO dateNov 10, 2022
CEOAinscow (Robert)
Number of employees136
Security typeOrdinary Share
Fiscal year-endNov 10
Address601 Pennsylvania Avenue Nw
CityWASHINGTON
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code20004
Phone12027562245
Websitehttps://aspisotopes.com/
Ticker SymbolASPI
IPO dateNov 10, 2022
CEOAinscow (Robert)

Company Executives of ASP Isotopes Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board
Executive Chairman of the Board
9.58M
-2.62%
Mr. Robert Ainscow
Mr. Robert Ainscow
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
2.28M
-0.37%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
1.53M
-1.52%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
1.04M
-1.11%
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
672.25K
-14.88%
Mr. Donald G. Ainscow
Mr. Donald G. Ainscow
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
400.00K
-25.00%
Prof. Michael (Mike) Gorley, Ph.D.
Prof. Michael (Mike) Gorley, Ph.D.
Independent Director
Independent Director
87.91K
-34.13%
Mr. Sipho Nkosinathi Maseko
Mr. Sipho Nkosinathi Maseko
Independent Director
Independent Director
58.97K
+61.98%
Dr. Hendrik Strydom, Ph.D.
Dr. Hendrik Strydom, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Robert Ryan
Mr. Robert Ryan
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board
Executive Chairman of the Board
9.58M
-2.62%
Mr. Robert Ainscow
Mr. Robert Ainscow
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
2.28M
-0.37%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
1.53M
-1.52%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
1.04M
-1.11%
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
672.25K
-14.88%
Mr. Donald G. Ainscow
Mr. Donald G. Ainscow
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
400.00K
-25.00%

FAQs

Who are the top five shareholders of ASP Isotopes Inc?

The top five shareholders of ASP Isotopes Inc are: Mr. Paul Elliot Mann

How many institutions hold shares of ASP Isotopes Inc (ASPI)?

As of 2026Q1, 345 institutions hold shares of ASP Isotopes Inc, with a combined market value of approximately 73.95M, accounting for 58.74% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 11377644.00.